Retraction Note to: Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway

. 2021 Sep 7;43(6):1621. doi: 10.1038/s41401-021-00730-4

PMCID: PMC9160029 PMID: 34493814

Correction to: Acta Pharmacologica Sinica 2019; 40:666-676; 10.1038/s41401-018-0159-7; published online 14 September 2018

The Editor-in-Chief has retracted this article. Concerns were raised regarding a number figures, specifically:

Figure 1E has been previously published as Figure 1D in¹.
Figure 1E: the upper left hand panel has been previously published in Figure 7B of²

The Editor-in-Chief therefore no longer has confidence in the reliability of the data reported in the article.

References

1.Han M, et al. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ. Biomed Pharmacotherapy. 2018;103:272–283. doi: 10.1016/j.biopha.2018.04.014. [DOI] [PubMed] [Google Scholar]
2.Liu K, Gao H, Wang Q, et al. Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer. Cancer Sci. 2018;109:1369–1381. doi: 10.1111/cas.13575. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]